CIPLA LIMITED FDA Approval ANDA 090371

ANDA 090371

CIPLA LIMITED

FDA Drug Application

Application #090371

Documents

Letter2009-11-24

Application Sponsors

ANDA 090371CIPLA LIMITED

Marketing Status

None (Tentative Approval)001

Application Products

001TABLET; ORAL200MG; 50MG0LOPINAVIR; RITONAVIRLOPINAVIR; RITONAVIR

FDA Submissions

ORIG1TA2009-11-20

Submissions Property Types

ORIG1Null1

CDER Filings

CIPLA LIMITED
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90371
            [companyName] => CIPLA LIMITED
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOPINAVIR; RITONAVIR","activeIngredients":"LOPINAVIR; RITONAVIR","strength":"200MG; 50MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LOPINAVIR; RITONAVIR","submission":"LOPINAVIR; RITONAVIR","actionType":"200MG; 50MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.